Finally, we found that the Taxifolin treatment significantly reduced the mRNA expression of genes related to inflammation and fibrosis in the tumorous lesions of the liver, without affecting Cd206, a representative marker for tumor-associated macrophages (Supplementary Materials Figure S3). The gene discussed is MRC1; the disease is neoplasm.